172 related articles for article (PubMed ID: 1700248)
1. Allergy treatment with a peptide vaccine.
Stanworth DR; Jones VM; Lewin IV; Nayyar S
Lancet; 1990 Nov; 336(8726):1279-81. PubMed ID: 1700248
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by nicotinamide of a homologous PCA reaction and antigen-induced histamine release from isolated rat peritoneal mast cells.
Wyczólkowska J; Maśliński C
Agents Actions; 1974 Aug; 4(3):202-3. PubMed ID: 4137728
[No Abstract] [Full Text] [Related]
3. Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester.
Agata M; Goto H; Tsuriya Y; Tachibana K; Kuroda T
Jpn J Pharmacol; 1982 Aug; 32(4):689-97. PubMed ID: 6182323
[TBL] [Abstract][Full Text] [Related]
4. Antigen-indued histamine release from peritoneal mast cells of mice producing reagin-like antibody.
Prouvost-Danon A; Peixoto JM; Javierre MQ
Immunology; 1968 Aug; 15(2):271-86. PubMed ID: 4175146
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effects of Freund's adjuvant treatment on mast cell histamine release and homocytotropic antibody synthesis.
Bergstrand H; Andersson I; Pauwels R; Bazin H
Int Arch Allergy Appl Immunol; 1985; 78(2):118-31. PubMed ID: 2412966
[TBL] [Abstract][Full Text] [Related]
6. [The pharmacological properties of a new anti-allergic agent, KP-136, in cutaneous models].
Kuriyama K; Hiyama Y; Ito K; Ichikawa K; Kitada S; Yoshinaka I
Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):213-24. PubMed ID: 2440785
[TBL] [Abstract][Full Text] [Related]
7. Characterization of allergoids from ovalbumin in vitro and in vivo.
Salgado J; Casadevall G; Puigneró V; Queralt J
Immunobiology; 1996; 196(4):375-86. PubMed ID: 9061378
[TBL] [Abstract][Full Text] [Related]
8. Active and passive cutaneous anaphylaxis in WBB6F1 mouse, a mast cell-deficient strain.
Arimura A; Nagata M; Takeuchi M; Watanabe A; Nakamura K; Harada M
Immunol Invest; 1990 Jun; 19(3):227-33. PubMed ID: 2365426
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by nicotinamide of an homologous PCA reaction and antigen-induced histamine release from rat peritoneal mast cells.
Wyczólkowska J; Maśliński C
Int Arch Allergy Appl Immunol; 1975; 49(3):285-92. PubMed ID: 50287
[TBL] [Abstract][Full Text] [Related]
10. Allergen-sensitization in vivo enhances mast cell-induced inflammatory responses and supports innate immunity.
Salinas E; Quintanar JL; Ramírez-Celis NA; Quintanar-Stephano A
Immunol Lett; 2009 Dec; 127(1):48-54. PubMed ID: 19733592
[TBL] [Abstract][Full Text] [Related]
11. Role of TGF-beta 1 on the IgE-dependent anaphylaxis reaction.
Kim HM; Lee YM
J Immunol; 1999 Apr; 162(8):4960-5. PubMed ID: 10202043
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of anaphylactic reaction of Sosiho-Tang.
Kim HM; Kim YY; Moon HS; Lee EH; Moon SJ; An NH
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):567-78. PubMed ID: 9805235
[TBL] [Abstract][Full Text] [Related]
13. Changes in bronchial anaphylactic reactivity induced in guinea-pigs by long-term treatment with histamine H2-agents.
Andersson P; Bergstrand H
Br J Pharmacol; 1984 May; 82(1):207-16. PubMed ID: 6203589
[TBL] [Abstract][Full Text] [Related]
14. Rosette-forming mast cells in rat anaphylaxis. Immunological characteristics of mast cell rosettes.
Wallach D; Renoux ML
Int Arch Allergy Appl Immunol; 1977; 55(1-6):152-60. PubMed ID: 73505
[TBL] [Abstract][Full Text] [Related]
15. The effect of rat mast cell sensitization with mouse IgE antibody on anaphylactic histamine release by anti-mouse IgE and Con A.
Brzezińska-Błaszczyk E; Wyczółkowska J
Arch Immunol Ther Exp (Warsz); 1985; 33(4):531-8. PubMed ID: 2417574
[TBL] [Abstract][Full Text] [Related]
16. Anaphylactic antibodies in the mouse. Relationship to mast cell degranulation during in vivo anaphylactic reactions.
Vaz EM; Silveira IH; Dodd VM; Monteiro MR; Vaz NM
Int Arch Allergy Appl Immunol; 1970; 39(5-6):459-68. PubMed ID: 5492271
[No Abstract] [Full Text] [Related]
17. Effects of Anemarrhena asphodeloides on IgE-mediated passive cutaneous anaphylaxis, compound 48/80-induced systemic anaphylaxis and mast cell activation.
Chai OH; Shon DH; Han EH; Kim HT; Song CH
Exp Toxicol Pathol; 2013 May; 65(4):419-26. PubMed ID: 22261360
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of an anti-allergic compound; 2,4-bis(2-acetoxy-benzamido) benzoic acid (AB-50): inhibition of anaphylactic and non-anaphylactic histamine release from rat peritoneal mast cells.
Ohsugi Y; Matsuno T; Takagaki Y
Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2437-43. PubMed ID: 73426
[No Abstract] [Full Text] [Related]
19. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
20. The effects of adrenergic blocking agents on passive cutaneous anaphylaxis reactions in the rat.
Tolone G; Bonasera L; Bruno R
Pathol Microbiol (Basel); 1971; 37(3):194-200. PubMed ID: 4107062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
